Provided by Tiger Fintech (Singapore) Pte. Ltd.

Summit Therapeutics PLC

27.07
+0.70002.65%
Post-market: 27.300.2300+0.85%19:59 EDT
Volume:1.92M
Turnover:51.12M
Market Cap:20.10B
PE:-79.72
High:27.44
Open:25.86
Low:25.41
Close:26.37
Loading ...

AstraZeneca beats profit expectations on robust drug sales, US demand

Reuters
·
29 Jul

Cantor Fitzgerald Remains a Buy on Summit Therapeutics (SMMT)

TIPRANKS
·
28 Jul

AstraZeneca shares show signs of life after successful trials of hypertension drug

Dow Jones
·
14 Jul

H.C. Wainwright Keeps Their Buy Rating on Summit Therapeutics (SMMT)

TIPRANKS
·
14 Jul

Summit Therapeutics (SMMT) Jumps 7.6% on Reports of $15-Billion AstraZeneca Deal

Insider Monkey
·
10 Jul

Why Summit Therapeutics (SMMT) Is Up 9.4% After Joining Major Russell Growth and Midcap Indices And What's Next

Simply Wall St.
·
10 Jul

Why Summit Therapeutics (SMMT) Is Up After AstraZeneca Licensing Talks For Cancer Drug

Simply Wall St.
·
07 Jul

Summit Therapeutics Stock (SMMT) Jumps 8% on Talks of $15B Licensing Deal with AstraZeneca

TIPRANKS
·
04 Jul

UK Stocks-Factors to watch on July 4

Reuters
·
04 Jul

Top Midday Stories: June Jobs Report Tops Expectations; Olo to be Acquired by Thoma Bravo for $10.25 Per Share

MT Newswires Live
·
03 Jul

BUZZ-Summit Therapeutics up on report of talks for licensing deal with AstraZeneca

Reuters
·
03 Jul

AstraZeneca discussing $15B partnership with Summit Therapeutics, Bloomberg says

TIPRANKS
·
03 Jul

Summit Therapeutics up 1% after report on AstraZeneca partnership talks

TIPRANKS
·
03 Jul

BRIEF-Summit Is Considering A $15 Billion Partnership With AstraZeneca - Bloomberg News

Reuters
·
03 Jul

Summit Therapeutics trading resumes

TIPRANKS
·
03 Jul

Summit Therapeutics (SMMT) Gets a Sell from Leerink Partners

TIPRANKS
·
02 Jul

Summit Therapeutics Initiated at Buy by UBS

Dow Jones
·
01 Jul

Summit Therapeutics (SMMT) Gets a Buy from Clear Street

TIPRANKS
·
01 Jul

Summit Therapeutics initiated with a Buy at UBS

TIPRANKS
·
01 Jul

Revolution Medicines, Summit Therapeutics Partner to Test Cancer Treatment Combinations

MT Newswires Live
·
30 Jun